MLM
32
5
PH
57
4
TAP
43
2
NOV
49
-6
BLK
46
2
RIG
41
-6
MAS
42
2
HCA
48
6
FTI
81
3
SIG
38
-3
CTSH
46
-3
ZBH
65
-3
LLY
37
4
LNC
28
-2
SLB
37
-4
ABT
57
3
UHS
60
4
TGNA
48
-2
YUM
33
-2
NDAQ
56
10
MLM
32
5
PH
57
4
TAP
43
2
NOV
49
-6
BLK
46
2
RIG
41
-6
MAS
42
2
HCA
48
6
FTI
81
3
SIG
38
-3
CTSH
46
-3
ZBH
65
-3
LLY
37
4
LNC
28
-2
SLB
37
-4
ABT
57
3
UHS
60
4
TGNA
48
-2
YUM
33
-2
NDAQ
56
10
Financhill
Back

Raymond James Financial Vs. Novo Nordisk AS Industry Stock Comparison

Buy
62

RJF
Raymond James Financial

Last Price:
$154.16
Seasonality Move:
8.63%
Sell
25

NVO
Novo Nordisk AS

Last Price:
$86.31
Seasonality Move:
6.68%
Buy
62
Raymond James Financial (RJF) is a Buy

Is Raymond James Financial a Buy, Sell or Hold?

  • The current Raymond James Financial [RJF] share price is $159.38. The Score for RJF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • RJF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.64. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RJF Stock Price Chart

What is Raymond James Financial's stock price today?

  • The Raymond James Financial share price today is $159.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RJF is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

RJF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 53.73 Buy
Chaikin Money Flow: 684437 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (155.08 - 162.68) Buy
Bollinger Bands (100): (122.72 - 160.32) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.06 Sell
Relative Strength Index (14 RSI): 31.71 Sell
Chaikin Money Flow: 6521757 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.72 - 109.1) Sell
Bollinger Bands (100): (99.51 - 129.55) Sell

RJF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 157.32 Buy
20-day SMA: 157.51 Buy
50-day SMA: 158.89 Buy
200-day SMA: 131.08 Buy
8-day EMA: 158 Buy
20-day EMA: 158.1 Buy
50-day EMA: 154.64 Buy
200-day EMA: 134.92 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.04 Sell
20-day SMA: 94.95 Sell
50-day SMA: 102.54 Sell
200-day SMA: 123.74 Sell
8-day EMA: 86.81 Sell
20-day EMA: 92.64 Sell
50-day EMA: 101.62 Sell
200-day EMA: 114.8 Sell

Raymond James Financial Earnings Growth & RJF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.14 per share, and an increase next year of $0.89 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.54 per share.

Raymond James Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):